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Blood Levels of Di（２‐Ethylhexyl）Phthalate（DEHP）in Hospitalized Patients
Yuki KUMIHASHI１）, Yuka OMOTE１）, Kazunori YAMAKAWA１）, Shiro ISHIDA２）, Yoshiro OKANO２）
１）Division of Pharmacy, Tokushima Red Cross Hospital
２）Faculty of Pharmaceutical Sciences, Tokushima Bunri University
Medical devices made of polyvinyl chloride contain di（２‐ethylehxyl）phthalate（DEHP ; a toxic substance having
testicular toxicity）as a plasticizer. In October ２００２，the Japanese health authority issued a medicine/medical
device safety alert, inviting precaution on the use of medical devices containing DEHP.
To investigate the distribution and fate of DEHP in vivo following the use of medical devices containing DEHP,
we recently measured blood and plasma DEHP levels in hospitalized patients. This study revealed the presence
of DEHP and MEHP（a metabolite of DEHP） in blood and plasma of the patients although in small amounts.
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